MKI67 and neoplasm: In our previous study, we have shown discrepancies in grading between primary gastroenteropancreatic NET and their metastatic sites in 35.3% of cases [46]. In 77.8% of patients with liver metastases, the Ki67 % was higher in liver lesions than in the primary tumour.